PT  - JOURNAL ARTICLE
AU  - Zheng, Biao
AU  - Hu, YongXian
AU  - Zhang, Jiqin
AU  - Zhang, Mingming
AU  - Li, Wei
AU  - Wu, Wenjun
AU  - Cui, Jiazhen
AU  - Wei, Guoqing
AU  - Du, Bing
AU  - Liu, Mingyao
AU  - Huang, He
TI  - 690 High safety and efficacy of CRISPR-Based non-viral PD1 locus specific Integrated Anti-CD19 CAR-T cells (BRL-201) in treating relapsed or refractory non-Hodgkin’s lymphoma: first-in-human phase I study
AID  - 10.1136/jitc-2023-SITC2023.0690
DP  - 2023 Nov 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - A782--A782
VI  - 11
IP  - Suppl 1
4099  - http://jitc.bmj.com/content/11/Suppl_1/A782.short
4100  - http://jitc.bmj.com/content/11/Suppl_1/A782.full
SO  - J Immunother Cancer2023 Nov 01; 11
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.